Global Monofilament Suture Market Size By Type (Absorbable Monofilament Suture, Non-absorbable Monofilament Suture), By Application (Human Application, Veterinary Application), By Region, And Segment...

The Global Monofilament Suture Market was valued at USD 1.7 billion in 2023 and is projected to reach USD 2.9 billion by 2031, growing at a CAGR of 6.8% during the forecast period from 2023 to 2031. The market is witnessing significant growth due to increasing surgical procedures globally, advancements in suture material technologies, and a rising focus on minimally invasive surgeries. Monofilament sutures are gaining traction for their smoother passage through tissues, lower infection risk, and reduced tissue trauma compared to multifilament alternatives, positioning them as a preferred choice across numerous surgical specialties.

Drivers:

1. Rising Number of Surgical Procedures:

The global rise in surgical interventions, including cardiovascular, orthopedic, and general surgeries, is boosting demand for monofilament sutures due to their reliability and reduced bacterial adherence.

2. Technological Advancements in Suture Materials:

Innovations in biodegradable and antimicrobial suture materials are enhancing the performance of monofilament sutures, supporting faster healing and reducing post-operative complications.

3. Increasing Preference for Minimally Invasive Surgeries:

The shift towards minimally invasive techniques that require precision and reduced trauma has led to increased adoption of monofilament sutures, which provide better control and minimal tissue drag.

Restraints:

1. High Cost of Advanced Sutures:

The cost of high-performance monofilament sutures, particularly those with antimicrobial coatings or biodegradable properties, can be a limiting factor, especially in cost-sensitive regions.

2. Limited Awareness in Emerging Markets:

In developing countries, lower awareness among healthcare providers regarding the advantages of monofilament sutures over traditional options can restrict market penetration.

Opportunity:

1. Expansion in Ambulatory Surgical Centers (ASCs):

The growing number of ASCs globally, due to increased demand for outpatient procedures, presents lucrative growth opportunities for monofilament suture manufacturers.

2. Rising Demand in Emerging Economies:

Healthcare infrastructure improvements and increased investment in surgical care in Asia-Pacific and Latin America are expected to fuel market expansion.

Market by System Type Insights:

Based on system type, Absorbable Monofilament Sutures held the largest market share in 2023. These sutures are widely used in internal tissue closures where long-term strength is not required, offering excellent handling and predictable absorption rates. Meanwhile, Non-absorbable Monofilament Sutures are gaining traction in cardiovascular and ophthalmic surgeries for their long-term tensile strength and minimal tissue reaction.

Market by End-use Insights:

In terms of end-use, Hospitals were the dominant segment in 2023, accounting for over 50% of the revenue share. The high volume of complex surgeries performed in hospitals, along with the availability of skilled professionals, drives this segment. However, Ambulatory Surgical Centers (ASCs) are anticipated to witness the fastest growth due to their cost-effectiveness and increasing adoption for same-day surgeries.

Market by Regional Insights:

Regionally, North America led the global monofilament suture market in 2023, driven by advanced healthcare infrastructure, a high number of surgical procedures, and strong presence of key players. Asia-Pacific is expected to register the highest growth during the forecast period, fueled by healthcare reforms, expanding surgical capacities, and rising awareness of advanced suture technologies in countries like China and India.

Competitive Scenario:

Leading players in the Global Monofilament Suture Market include Johnson & Johnson (Ethicon), Medtronic plc, B. Braun Melsungen AG, Smith & Nephew plc, Boston Scientific Corporation, DemeTECH Corporation, Peters Surgical, and Surgical Specialties Corporation. These companies are focusing on expanding their product portfolios through R&D investments, regulatory approvals, and strategic collaborations.

Key Developments:

In 2023, Ethicon launched a next-gen antibacterial monofilament suture with enhanced tensile strength and extended absorption profile.

In 2024, Medtronic introduced a biodegradable monofilament suture designed for cardiovascular applications with faster tissue integration.

In 2025, B. Braun expanded its production facilities in Asia-Pacific to cater to rising regional demand for surgical sutures.

Scope of Work – Global Monofilament Suture Market

Report Metric Details

Market Size (2023) USD 1.7 billion

Projected Market Size (2031) USD 2.9 billion

CAGR (2023–2031) 6.8%

Market Segments By System Type (Absorbable, Non-absorbable); By End-use; Region

Growth Drivers Rising surgical volumes, technological innovation

Opportunities ASC expansion, emerging markets demand

FAQs:

1) What is the current market size of the Global Monofilament Suture Market?

The market was valued at USD 1.7 billion in 2023.

2) What is the major growth driver of the Global Monofilament Suture Market?

Rising global surgical volumes and advancements in suture material technology are key drivers.

3) Which is the largest region during the forecast period in the Global Monofilament Suture Market?

North America is expected to maintain the largest market share.

4) Which segment accounted for the largest market share in the Global Monofilament Suture Market?

Absorbable Monofilament Sutures led the market by system type in 2023.

5) Who are the key market players in the Global Monofilament Suture Market?

Johnson & Johnson (Ethicon), Medtronic, B. Braun Melsungen AG, and Smith & Nephew are among the key players.

Would you like this report in DOCX or PDF format for download?